Zobrazeno 1 - 10
of 15
pro vyhledávání: '"N I, Wedel"'
Autor:
M. A. M. Von Der Möhlen, N. I. Wedel, B. J. Nelson, B. Van Den Ende, Nadav Friedmann, J W ten Cate, S. J. H. Van Deventer, Marcel Levi
Publikováno v:
Blood, 85(12), 3437-3443. American Society of Hematology
A recombinant endotoxin-neutralizing protein, rBPI23, was shown to partially prevent endotoxin-induced activation of the fibrinolytic and coagulation systems in experimental endotoxemia in humans. In a placebo-controlled, blinded crossover study, eig
Autor:
D J, Norman, F, Vincenti, A M, de Mattos, J M, Barry, D J, Levitt, N I, Wedel, M, Maia, S E, Light
Publikováno v:
Transplantation. 70(12)
HuM291 is a humanized anti-CD3 monoclonal antibody engineered to reduce binding to Fcgamma receptors and complement fixation. HuM291 has a long serum half-life and mediated profound depletion of circulating T cells in chimpanzees; HuM291 also has sig
Autor:
M. A. M. von der Mohlen, A. N. Kimmings, N. I. Wedel, M. L. C. M. Mevissen, J. Jansen, N. Friedmann, T. J. Lorenz, B. J. Nelson, M. L. White, R. Bauer, C. E. Hack, A. J. M. Eerenberg, S. J. H. van Deventer
Publikováno v:
The Journal of infectious diseases. 172(1)
To investigate the effects of a recombinant endotoxin-binding protein, bactericidal/permeability-increasing protein (rBPI23), on cytokine release and neutrophil activation in endotoxemia in humans, 8 volunteers were challenged twice with endotoxin an
Publikováno v:
Progress in clinical and biological research. 367
Xomen-E5 (E5) is a murine monoclonal IgM antibody (MAb) that binds to the lipid A epitope of endotoxin. The MAb was developed by immunization against the J5 mutant of Escherichia coli. Prior studies in humans have shown safety and T1/2 of 18.4 hours.
Autor:
Hasan, Mahbub1,2 (AUTHOR), Choi, Jong‐Gu1 (AUTHOR), Akter, Hafeza1 (AUTHOR), Kang, Hasung3 (AUTHOR), Ahn, Meejung4 (AUTHOR), Lee, Sang‐Suk1 (AUTHOR) sslee@sangji.ac.kr
Publikováno v:
Advanced Science. 3/20/2024, Vol. 11 Issue 11, p1-13. 13p.
Autor:
N. I. Wedel, Marijke A. M. Von Der Mohlen, B. J. M. Delemarre, Robbert J. de Winter, Sander J. H. van Deventer
Publikováno v:
Journal of the American College of Cardiology. 25:76A
The protective effect of rBPI23on the circulatory changes induced by experimental endotoxemia in humans was tested in a controlled blinded crossover study. Eight healthy male volunteers were challenged twice with an intravenous bolus injection of end
Autor:
L E, Spitler, M, del Rio, A, Khentigan, N I, Wedel, N A, Brophy, L L, Miller, W S, Harkonen, L L, Rosendorf, H M, Lee, R P, Mischak
Publikováno v:
Cancer research. 47(6)
We conducted a trial of a murine monoclonal antimelanoma antibody-ricin A chain immunotoxin (XOMAZYME-MEL) in 22 patients with metastatic malignant melanoma. The dose of immunotoxin administered ranged from 0.01 mg/kg daily for 5 days to 1 mg/kg dail
Autor:
Giroir, Brett P., Quint, Peter A.
Publikováno v:
Lancet. 11/15/1997, Vol. 350 Issue 9089, p1439. 5p. 3 Charts, 2 Graphs.
Autor:
CATANIA, ANNA, CUTULI, MARIAGRAZIA, GAROFALO, LETIZIA, CARLIN, ANDREA, AIRAGHI, LORENA, BARCELLINI, WILMA, LIPTON, JAMES M.
Publikováno v:
Annals of the New York Academy of Sciences; 2000, Vol. 917 Issue 1, p227-231, 5p
Autor:
VANDERMEER, THOMAS J., MENCONI, MICHAEL J., O'SULLIVAN, BRIAN P., LARKIN, VERA A., HAILONG WANG, KRADIN, RICHARD L., FINK, MITCHELL P.
Publikováno v:
Journal of Applied Physiology; 1994, Vol. 76 Issue 5, p2006-2014, 9p